Related Experiment Video

Updated: Sep 16, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

679

Topical ruxolitinib vs topical roflumilast for itch reduction in atopic dermatitis: A comparative meta-analysis

Grace Xiong1, Sana Gupta2, Vinesh Rao3

  • 1Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

Journal of the American Academy of Dermatology
|July 5, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
atopic dermatitismedical dermatologymeta-analysispruritusrandomized clinical trialroflumilastruxolitinib

More Related Videos

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.3K
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.4K

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
489